NPIPA7
gene geneOn this page
Summary
NPIPA7 (nuclear pore complex interacting protein family member A7, HGNC:41982) is a protein-coding gene on chromosome 16p13.11, encoding Nuclear pore complex-interacting protein family member A7 (E9PJI5).
At a glance
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_001282507
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:41982 |
| Approved symbol | NPIPA7 |
| Name | nuclear pore complex interacting protein family member A7 |
| Location | 16p13.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000214967 |
| Ensembl biotype | protein_coding |
| Entrez | 101059938 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 8 protein_coding
ENST00000344087, ENST00000530217, ENST00000941805, ENST00000941806, ENST00000941807, ENST00000941808, ENST00000941809, ENST00000941810
RefSeq mRNA: 1 — MANE Select: NM_001282507
NM_001282507
CCDS: CCDS61864
Canonical transcript exons
ENST00000530217 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002146862 | 16383664 | 16383792 |
| ENSE00002183165 | 16387399 | 16387498 |
| ENSE00003481631 | 16391891 | 16391951 |
| ENSE00003489318 | 16387662 | 16387806 |
| ENSE00003540895 | 16390767 | 16390874 |
| ENSE00003612167 | 16392061 | 16392096 |
| ENSE00003978243 | 16393456 | 16393972 |
| ENSE00003978244 | 16379140 | 16379307 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 96.78.
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pituitary gland | UBERON:0000007 | 96.78 | gold quality |
| adenohypophysis | UBERON:0002196 | 96.78 | gold quality |
| primary visual cortex | UBERON:0002436 | 95.30 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 95.07 | gold quality |
| cerebellar cortex | UBERON:0002129 | 94.93 | gold quality |
| cerebellum | UBERON:0002037 | 94.92 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 94.81 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 94.14 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 92.32 | gold quality |
| right testis | UBERON:0004534 | 92.23 | gold quality |
| right uterine tube | UBERON:0001302 | 91.74 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 91.08 | gold quality |
| left testis | UBERON:0004533 | 90.95 | gold quality |
| body of pancreas | UBERON:0001150 | 90.87 | gold quality |
| thyroid gland | UBERON:0002046 | 90.62 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 90.52 | gold quality |
| testis | UBERON:0000473 | 90.44 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 90.02 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 89.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 89.63 | gold quality |
| spleen | UBERON:0002106 | 89.61 | gold quality |
| cortex of kidney | UBERON:0001225 | 89.44 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 89.40 | gold quality |
| fundus of stomach | UBERON:0001160 | 89.30 | gold quality |
| right adrenal gland | UBERON:0001233 | 89.27 | gold quality |
| right lobe of liver | UBERON:0001114 | 89.10 | gold quality |
| metanephros cortex | UBERON:0010533 | 88.75 | gold quality |
| transverse colon | UBERON:0001157 | 88.65 | gold quality |
| rectum | UBERON:0001052 | 88.33 | gold quality |
| right ovary | UBERON:0002118 | 88.31 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.21 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (19): NPIPB12 (ENSG00000169203), NPIPB3 (ENSG00000169246), NPIPA1 (ENSG00000183426), NPIPA5 (ENSG00000183793), NPIPA6 (ENSG00000183889), NPIPB4 (ENSG00000185864), NPIPB15 (ENSG00000196436), NPIPB9 (ENSG00000196993), NPIPB13 (ENSG00000198064), NPIPB6 (ENSG00000198156), NPIPA8 (ENSG00000214940), NPIPA3 (ENSG00000224712), NPIPA9 (ENSG00000233024), NPIPB7 (ENSG00000233232), NPIPB2 (ENSG00000234719), NPIPB5 (ENSG00000243716), NPIPB11 (ENSG00000254206), NPIPA2 (ENSG00000254852), NPIPB8 (ENSG00000255524)
Protein
Protein identifiers
Nuclear pore complex-interacting protein family member A7 — E9PJI5 (reviewed: E9PJI5)
All UniProt accessions (2): E9PJI5, H0Y2X3
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the NPIP family.
RefSeq proteins (1): NP_001269436* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR009443 | NPIP | Family |
| IPR054697 | NPIP_N | Domain |
Pfam: PF06409
UniProt features (2 total): chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-E9PJI5-F1 | 52.06 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 3 (showing top):
HOEK_NK_CELL_2011_2012_TIV_ADULT_3DY_UP, HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL, chr16p13
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
549 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NPIPA7 | FAM76A | Q8TAV0 | 654 |
| NPIPA7 | PNMA6A | P0CW24 | 541 |
| NPIPA7 | ETFRF1 | Q6IPR1 | 507 |
| NPIPA7 | ECT2L | Q008S8 | 506 |
| NPIPA7 | TC2N | Q8N9U0 | 448 |
| NPIPA7 | CD300LD | Q6UXZ3 | 447 |
| NPIPA7 | PLEKHB2 | Q96CS7 | 435 |
| NPIPA7 | GALNT4 | Q8N4A0 | 399 |
| NPIPA7 | NGLY1 | Q96IV0 | 354 |
| NPIPA7 | NUDT8 | Q8WV74 | 353 |
| NPIPA7 | COX15 | Q7KZN9 | 338 |
| NPIPA7 | GEMIN4 | P57678 | 324 |
| NPIPA7 | PLS3 | P13797 | 297 |
| NPIPA7 | CELF2 | O95319 | 267 |
| NPIPA7 | CCDC12 | Q8WUD4 | 262 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NPIPA7 | HMBOX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NPIPA7 | TRAF4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAF4 | NPIPA7 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (1): NPIPA7 (Affinity Capture-RNA)
ESM2 similar proteins: A0A0B4J1W7, A0A7H0DN35, A4QN01, A6NHN6, A6NJ64, A8MQ11, E9PIF3, E9PJ23, E9PJI5, E9PKD4, E9PQR5, F5HGC2, F8W1W9, F8WFD2, O75200, O83374, P05913, P06486, P07396, P0C7Q2, P0CK47, P0CK48, P0DM63, P0DXC3, P15489, P16765, P16802, P20969, P36443, P38900, P47003, P68341, P68454, P68455, P87191, P92537, P92561, Q03418, Q32M92, Q4ZGE2
Diamond homologs: A0A0B4J1W7, A6NHN6, A6NJ64, A6NJU9, A8MRT5, C9JG80, E5RHQ5, E9PIF3, E9PJ23, E9PJI5, E9PKD4, E9PQR5, F8W0I5, F8W1W9, F8WFD2, O75200, P0DM63, P0DXC3, Q92617, Q9UND3, O70490, Q08AH1, Q08AH3, Q3UNX5, Q53FZ2, Q5REV5, Q68CK6, Q6AYT9, Q6NUN0, Q6SKG1, Q8BGA8, Q8K0L3, Q91VA0, Q9BEA2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1111 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:16383711:TGG:T | donor_gain | 1.0000 |
| 16:16383713:G:GT | donor_gain | 1.0000 |
| 16:16383788:TTTGT:T | donor_gain | 1.0000 |
| 16:16383789:TTGT:T | donor_gain | 1.0000 |
| 16:16383791:GT:G | donor_gain | 1.0000 |
| 16:16383793:G:GG | donor_gain | 1.0000 |
| 16:16383794:T:TC | donor_loss | 1.0000 |
| 16:16383795:GAGTA:G | donor_loss | 1.0000 |
| 16:16383796:AGTA:A | donor_loss | 1.0000 |
| 16:16387398:GGT:G | acceptor_gain | 1.0000 |
| 16:16387473:G:GT | donor_gain | 1.0000 |
| 16:16387494:GGAAG:G | donor_gain | 1.0000 |
| 16:16387495:GAAGG:G | donor_gain | 1.0000 |
| 16:16387496:A:T | donor_gain | 1.0000 |
| 16:16387802:GAACA:G | donor_gain | 1.0000 |
| 16:16387807:G:GG | donor_gain | 1.0000 |
| 16:16390765:A:AG | acceptor_gain | 1.0000 |
| 16:16390766:G:GG | acceptor_gain | 1.0000 |
| 16:16390766:GTCT:G | acceptor_gain | 1.0000 |
| 16:16390875:G:GG | donor_gain | 1.0000 |
| 16:16391952:G:GG | donor_gain | 1.0000 |
| 16:16383658:TTCCA:T | acceptor_loss | 0.9900 |
| 16:16383659:TCCA:T | acceptor_loss | 0.9900 |
| 16:16383660:CCAGG:C | acceptor_loss | 0.9900 |
| 16:16383661:CAG:C | acceptor_loss | 0.9900 |
| 16:16383662:A:G | acceptor_loss | 0.9900 |
| 16:16383663:G:C | acceptor_loss | 0.9900 |
| 16:16383663:GGTT:G | acceptor_gain | 0.9900 |
| 16:16383712:GGA:G | donor_gain | 0.9900 |
| 16:16387394:CCTA:C | acceptor_loss | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1003052961 (16:16387584 C>T), RS1004836112 (16:16387539 T>G), RS1004891623 (16:16390658 G>T), RS1008729081 (16:16386901 C>T), RS1009010242 (16:16386121 C>T), RS1011208435 (16:16382355 G>A,T), RS1014840641 (16:16387540 G>T), RS1015120509 (16:16387068 G>GTC,GTT), RS1018748892 (16:16386910 T>C), RS1019027429 (16:16386251 G>A), RS1020813637 (16:16386080 A>T), RS1021760374 (16:16390782 C>A,T), RS1027671761 (16:16386940 C>A,T), RS1028034582 (16:16386411 A>AGTGTAC), RS1034545345 (16:16387618 G>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate | affects cotreatment, increases expression | 1 |
| perfluorooctanoic acid | affects cotreatment, increases expression | 1 |
| perfluorooctane sulfonic acid | affects cotreatment, increases expression | 1 |
| perfluorobutanesulfonic acid | affects cotreatment, increases expression | 1 |
| Vehicle Emissions | increases abundance, increases expression | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Doxorubicin | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Cadmium Chloride | increases abundance, decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.